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Introduction
Colon/rectum (colorectal) cancer (CRC) is a leading 
cause of mortality worldwide. This cancer is the third 
prevalent cancer leading to death in western countries 
(Merrill et al., 2013). The incidence varies in different 
communities and is declining in the United States and 
Europe (Jackson et al., 2006; Zheng et al., 2013) and 
increasing in Asian countries (Sung et al., 2005). In 
2008, 608700 new cases of CRC were diagnosed and 1.2 
million death was reported (Choe et al., 2005; Merrill et 
al., 2013). The age adjusted incidence of colorectal cancer 
is reported to be 9 cases per 100000 among women and 
11 cases among 100000 men in Iran (Mohagheghi et al., 
2009). Ethnic or racial disparity has been noted between 
black and white as well as native and non-natives in 
United States, New Zealand, and Australia (Ward et al., 
2004; Jeffreys et al., 2005; Albano et al., 2007; Hill et al., 
2010; Zheng et al., 2013). The survival rate of CRC is 
lower in developing countries than developed countries. 
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Abstract
 Background: Colorectal cancer (CRC) is an important cause of mortality and morbidity in many communities 
worldwide. This population based study was conducted to assess determinants of colorectal mortality in Iranian 
patients. Materials and Methods: A cohort of 1,127 cases of confirmed colorectal cancer registered in a population 
based registry covering 10 referral hospital in Tehran, Iran, were followed for five years. Information about tumor 
characteristics, smoking status and family history were collected at base line and survival status were followed 
every six months by contacting patient or next of kin (if patients died during the follow-up). The cause of death 
for each case was validated by verbal autopsy and referring to patient medical records at the time of death. The 
data were analyzed by Stata software using univariate and multivariate analysis (Cox regression). In building the 
model a p value of less than 5% was considered as significant. Results: The age at diagnosis was 53.5±14 years. 
Sixty one percent were male. Colorectal mortality among the patients was 96.9 person-years among men and 83 
person-years among women. Seventy five percent of patients lived for 2.72 years, 50% for 5.83, and 25% for 13 
years after the diagnosis of colorectal cancer. The age at diagnosis was significantly different between men and 
women (p<0.03).  Higher tumor grade predicted higher death rate; the adjusted hazard ratios were 1.79 (95%CI, 
0.88-3.61), 2.16 (95%CI, 1.07-4.37), and 3.1 (95%CI, 1.51-6.34) for grades II, III, and IV respectively when they 
were compared with grade I as reference. Ethnicity, marital status, family history of cancer, and smoking were 
related to survival with different degrees of magnitude. Conclusions: Among many factors related to survival 
among the colorectal patients, tumor grade and smoking showed the highest magnitudes of association. 
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In developing countries, diagnosis is made more in later 
stages of the cancer and there is a limited access to quality 
diagnostic and therapeutic services (Jemal et al., 2011). 
Although the mortalities due to CRC are decreasing in the 
United States, there are ethnic and racial disparities in its 
outcome. Ethnic minorities are less willing to screen for 
CRC (Perencevich et al., 2013). Socioeconomic status 
(SES) is inversely correlated with increased risk of CRC. 
The risk of CRC is higher by 30% in low SES than high 
SES (Doubeni et al., 2012). The CRC is rapidly rising in 
countries adapting western lifestyle characterized with 
higher meat and fat consumption and lower physical 
activities (Ponz de Leon et al., 2004). The incidence of 
CRC is more frequently observed in the individuals over 
55 years. Access to diagnostic and therapeutic services 
play very important role in ethnic disparity seen in CRC 
burden (Hill et al., 2010). During the period of 1998-2001, 
the overall cancer age-standardized rates (ASR) were 
163.0 per 100,000 males and 141.8 per 100,000 females 
in Iran. A study in Iran in 2008 reported that the median 
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survival time after CRC diagnosis was 3.5 years. No 
population based data on outcome and survival among 
CRC patients has been reported in Iran. The aim of this 
study to present the survival and assess determinants 
of survival among CRC from a population based CRC 
registry in Iran.
Materials and Methods
This is a prospective cohort study. The required data 
were obtained from Colorectal Cancer Registry Database 
of the Research Center for Gastroenterology and Liver 
Diseases affiliated to Shahid Beheshti University of 
Medical Sciences. These data are relevant to the patients 
referring 10 public and private hospitals in Tehran, 
which refer the CRC patients to the Colorectal Cancer 
Registry. The study was initiated at September 23, 2006 
and the patients were followed up till October 23, 2011. 
Information about tumor characteristic, smoking status, 
family history was collected at base line and survival status 
was followed every six months by contacting patient or 
next of kin (if patient died during the follow-up). The cause 
of death for each case was validated by verbal autopsy 
and referring to patient’ medical record at the time of 
death. To assess the determinants of survival and eliminate 
confounding variables, we used the Cox proportional 
hazard model. The variables approximate to the level of 
significance (p<0.2) were entered into multivariate Cox 
regression model. In building model, Schoenfeld test with 
a p- vale of less than 5% was considered as statistically 
significant to enter into the model. Proportional hazard 
was assessed for the variables entered into the model using 
and yielded as established. A PP<0.05 was considered 
as the level of significance. The data were analyzed by 
Stata software Stata software (version 12). All cases 
of CRC had diagnosed histoptahologic confimatioin of 
diagnosis. Tumor grade was established by the criteria of 
International Classification of Diseases (the code C18-
21), the pathology report, and the criteria of American 
Commission of Cancer.
Results 
A total of 1127 cases of CRC with 2758 pearson years 
of followup contributed to this study. Out of 1127 cases, 
690 (61%) were male and 530 (39%) female. The patients’ 
age range was 14 to 94 years. Mean (SD) age at CRC 
diagnosis was 53.5 (14) years. Thirty point two percent 
of the patients were under 45 years, 45.5% were 45-65 
years, and 24.3% were over 65 years. Most of patients 
(55.5%) were diagnosed as having CRC in the first stage 
of the disease. The advanced stages of disease were more 
prevalent in older patients (p=0.012). The adjusted hazard 
ratio (95% Confidence Interval’s: CI) of mortality was 
1.79(0.88-3.61), 2.16 (1.07-4.37), and 3.1(1.51-6.34) at 
grades of respectively II, III, and IV with reference to 
grade I. A curve of the patients’ survival was plotted for 
cancer grades with confidence interval 95% (Figure 1). 
Cancer grades, Ethnicity, marital status, family history 
of cancer, and smoking were determinants of survival 
in the patients. Patients’ characteristics for demographic 
Table 1. Patients’ Characteristics for Demographic 
Variables and Mortality Rate Due to CRC
Variable percent death Mortality CI95%
   Rate IMR
Tumor Grade     
 I 8.34 9 47.5 24.7-91.3
 II 36.77 67 75.5 59.4-96
 III 36.56 69 93.6 73.8-117.8
 IV 18.33 56 139.1 107.1-869
Ethnicity 
 Fars 52 120 94.5 79-113.1
 Kurd 8.2 15 103.7 62.4-171.9
 Lur 7.5 16 88.7 54.3-144.8
 Turk 21.5 38 70.8 51.5-97.3
 Others 10.8 46 153 114.6-204.2
Gender 
 Men 61.3 150 96.9 82.9-113.8
 women 38.7 85 83 67.1-102.7
Marital status 
 Married 93 197 85.3 74.2-98.1
 Non married 7 24 161 107.9-240.3
Education 
 Illitrate 26.5 56 113 86.9-146.8
 Primary 32.2 49 79.8 60.3-105.5
 High school 24.5 35 76.2 54.7-106.1
 University 16.8 31 80 56.3-113.9
Disease Stage  
 First stage 45.2 76 70.6 56.4-88.4
 Advanced  54.8 124 109.8 92-131
Age groups 
 < 45 30.2 73 89 70.8-112
 45-65 45.5 99 83 68.6-101
 > 65 24.3 63 111 87-142
     
Family history 
 No 63.2 145 99 84-116
 yes 36.8 79 78 62-97
Smoking 
 No 73.5 150 86.8 64-101.9
 yes 26.5 65 101.5 79.6-121.5
Figure 1. A Cirve of the Patient’s Surval for Cancer 
Grades with Confidence Interval 95%
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Figure 1.A curve of the patients’ survival for cancer grades with confidence interval 95%.
variables and mortality rate due to CRC are shown in 
Table 1. Hazard Ratio of death yielded by univariate and 
multivariate Cox regression is shown in Table 2. 75%, 
50%, and 25% of the patients survived respectively 2.72, 
5.83, and 13 years or longer after diagnosis. Relative 
risk for Kurds was obtained 1.95 and significant by Cox 
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regression model (p=0.046) as other variables were present 
in model and the confounding variables were controlled. 
Relative risk was lowest (0.44) in Lurs. Median survival 
time was 5.8, 4.8, 5.4, 8.5, 3.7, and 5.8 years in Fars, 
Kurds, Lurs, Turks, others, and all patients respectively. 
Discussion
In our study, the crude median survival time for CRC 
patients was 5.83 years and tumore grade, family history, 
age were the major determinant of mortality. Difrent 
ethnicity Disparity in relative risk of CRC was seen among 
different ethnicity in Iranian population. Our findings are 
consistent with a study in the United States that reported 
disparities in incidence rate of cancer between Hispanic 
whites and non Hispanic populations. In this study, CRC 
and its associated mortalities were strongly and inversely 
correlated with the level of education and literacy. CRC 
survival in illiterate patients was lower compared to rate 
in literate people, which is in agreement with earlier 
studies in other countries (Albano et al., 2007; Doubeni 
et al., 2012). 
The grade of CRC at diagnosis was an important and 
significant variable in the model, which is consistent 
with other studies (Jeffreys et al., 2005). CRC-associated 
mortalities were higher in above 65-year-old patients 
compared to the other age groups. By log-rank test, there 
was no significant difference in survival between men 
and women. The age at diagnosis was two years lower for 
women than men. This finding is probably in agreement 
with other studies reporting that women follow healthcare 
more seriously and have higher rate of participation in 
screening plans compared to men (Krieger et al., 1999; 
Pahlavan et al., 2006; van Jaarsveld et al., 2006; Safaee 
et al., 2012; Mobasheri and Ahmadi, 2014). 
In the present study, smoking increased the risk of 
death in the patients, which is consistent with a study in the 
United States that reported smoking increased mortality 
risk after CRC diagnosis (Phipps et al., 2011). In our study, 
36.8% of the patients had family history of CRC, which 
is higher than a study in Sari, northern Iran reporting 
family history of CRC 24%. In this study, risk of death 
was lower in the patients with family history of CRC than 
those without such history. Willingness to do screening, 
early diagnosis, and/or more prophylatic practices in 
the patients with family history of cancer could explain 
decreased risk of death. However, a study in Germany 
reported that smoking and being male were more effective 
on CRC compared to family history (Hoffmeister et al., 
2010). The median of survival time after CRC treatment 
was 4-13 months in the present study and 15.4 months in 
a study in the United States (Yuste et al., 2003). 
In our study, survival of the married individuals was 
higher than the non married, which is in agreement with 
similar studies (Johansen et al., 1998; Goldzweig et al., 
2009). The demographic determinants of the patients’ 
survival in the present study are similar to and consistent 
with other studies. Risk ratio for the mortality due to CRC 
has been reported in view of ethnicity. Therefore, through 
determining the above-mentioned variables, policy makers 
and planners of health system could pay more attention 
to access to and quality of the diagnostic and therapeutic 
services in Iranian ethnics, attempt to promote access to 
these services in ethnics with shorter survival, and hence 
decrease disparity in survival time in different ethnics. 
This study recommends further investigations 
be conducted to determine genetic or environmental 
reasons for the disease including the diet and cultural 
and behavioral habits in different ethnicities to identify 
the causes of the difference in CRC survival among the 
ethnicities. Although some patients from other Iranian 
ethnics are likely to refer the hospitals in Tehran, one of 
the limitations of this study was that it was conducted only 
in Tehran and therefore the findings should be cautiously 
generalized to other Iranian ethnics. Also, conduction of 
a population-based work with enrollment of a satisfactory 
sample size including all Iranian ethnics in subsequent 
studies is recommended.
Table 2. Hazard Ratio of Death by Univariate and Multivariate Cox Regression
Variable  Univariate HR: 95%CI Multivariate HR: 95%CI p value
Tumor Grade I Reference - - -
 II 1.58:0.78-3.19 1.79 0.88-3.61 0.105
 III 2:0.99-4.03 2.11 1.19-3.75 0.032
 IV 2.81:1.31-5.71 3.1 1.51-6.34 0.002
Ethnicity Fars Reference - - -
 Kurd 1.1:0.6-1.8 1.95 1.01-3.76 0.046
 Lur 0.9: 0.5-1.6 0.44 0.18-1.07 0.071
 Turk 0.7: 0.5-1.1 0.59 0.33-1.04 0.071
 Others 1.6: 1.1 -2.3 1.44 0.78-2.67 0.45
Marital status Married Reference - - -
 Non married 1.8: 1.2-2.8 2.14 1.19-3.84 0.01
Education Illitrate 1.4:0.9-2.1 1.54 0.89-2.68 0.12
 Primary 0.9:0.6-1.5 0.93 0.53-1.63 0.806
 High school 0.9:0.5-1.5 0.94 0.51-1.72 0.849
 University Reference - - -
Age at diagnosis  1.2:0.9-1.7 1.01 0.98-1.01 0.611
Family history No Reference - - -
 Yes 0.7:0.6 -1.1 0.58 0.38 -0.89 0.014
Smoking No Reference - - -
 Yes 1.1:0.8-1.5 1.55 1.03-2.34 0.036
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